Jay Backstrom
Chief Executive Officer chez SCHOLAR ROCK HOLDING CORPORATION
Fortune : 6 M $ au 31/03/2024
Postes actifs de Jay Backstrom
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| LAVA THERAPEUTICS N.V. | Director/Board Member | 15/06/2022 | - |
| SCHOLAR ROCK HOLDING CORPORATION | Director/Board Member | 20/10/2022 | - |
| Chief Executive Officer | 20/09/2022 | - | |
| President | 20/10/2022 | - | |
Be Biopharma, Inc.
 Be Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Be Biopharma, Inc. develops engineered B cells as a new category of cellular medicines. The company was founded by David Steinberg, Aleks Radovic-Moreno and Lea Hachigian and is headquartered in Cambridge, MA. | Director/Board Member | 16/12/2021 | - |
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Director/Board Member | 01/12/2021 | - |
Pancreatic Cancer Action Network, Inc.
 Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Pancreatic Cancer Action Network, Inc. engages in the research, clinical initiatives, patient services, and advocacy for pancreatic cancer. The company was founded in 1999 and is headquartered in Manhattan Beach, CA. | Director/Board Member | 01/07/2023 | - |
Historique de carrière de Jay Backstrom
Anciens postes connus de Jay Backstrom
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| DISC MEDICINE, INC. | Director/Board Member | 01/09/2021 | 09/06/2023 |
| AUTOLUS THERAPEUTICS PLC | Director/Board Member | 01/08/2020 | 28/02/2023 |
| Independent Dir/Board Member | 01/08/2020 | 28/02/2023 | |
| ACCELERON PHARMA INC. | Chief Tech/Sci/R&D Officer | 09/12/2019 | 01/12/2021 |
| CELGENE | Chief Tech/Sci/R&D Officer | 01/04/2016 | 01/11/2019 |
| Corporate Officer/Principal | 01/01/2008 | 01/04/2016 | |
| ░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Formation de Jay Backstrom
| St Louis University School of Public Health | Graduate Degree |
| Lewis Katz School of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 13 |
| Royaume-Uni | 2 |
| Pays-Bas | 2 |
Opérationnelle
| Director/Board Member | 8 |
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Health Technology | 9 |
| Health Services | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| LAVA THERAPEUTICS N.V. | Health Technology |
| Entreprise privées | 10 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Pharmion Corp.
 Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO. | Health Technology |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
| Samuel U. Rodgers Community Health Center, Inc. | |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Pancreatic Cancer Action Network, Inc. engages in the research, clinical initiatives, patient services, and advocacy for pancreatic cancer. The company was founded in 1999 and is headquartered in Manhattan Beach, CA. | Health Services |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Health Technology |
Be Biopharma, Inc.
Be Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Be Biopharma, Inc. develops engineered B cells as a new category of cellular medicines. The company was founded by David Steinberg, Aleks Radovic-Moreno and Lea Hachigian and is headquartered in Cambridge, MA. | Commercial Services |
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA. | Health Technology |
| Disc Medicine, Inc. |
- Bourse
- Insiders
- Jay Backstrom
- Expérience
